The National Institutes of Health (NIH) has announced a new funding opportunity under the number RFA-CA-24-009, aimed at the advanced development and validation of emerging molecular and cellular analysis technologies for cancer research. This grant falls under the category of discretionary grants and is targeted towards the fields of education and health, specifically focusing on cancer detection and diagnosis research as indicated by the CFDA number 93.394. The grant offers a unique opportunity for research projects that are at a stage where major feasibility gaps in technology or methodology have been overcome but still require further development and validation. With an award ceiling of $300,000, the grant seeks to support projects up until October 1, 2024, providing a significant window for research initiatives.
This funding opportunity is part of the broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program and is specifically tailored for exploratory research projects. The aim is to target, probe, or assess molecular and cellular features of cancer biology for basic or clinical cancer research. The NIH is seeking applications for projects that have already demonstrated some level of feasibility with preliminary data but need further development to encourage wider adoption within the research community. The technologies proposed for development should have broad applicability and focus on improving molecular and/or cellular characterizations of cancer. This grant is not intended for projects that simply apply existing technologies to new biological or clinical questions but rather for those that bring novel capabilities to the field. This initiative holds great potential for accelerating and enhancing research in cancer biology, early detection, screening, diagnosis, treatment, and control, as well as addressing issues related to cancer health disparities. This opportunity is open to a wide range of eligible applicants including small businesses, educational institutions, government entities, and various non-profit organizations. It represents a crucial step forward in the fight against cancer by fostering the development of cutting-edge technologies in molecular and cellular analysis.
Opportunity ID: 351208
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-24-009 |
| Funding Opportunity Title: | Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | |
| Expected Number of Awards: | |
| CFDA Number(s): | 93.394 — Cancer Detection and Diagnosis Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Nov 29, 2023 |
| Last Updated Date: | Nov 29, 2023 |
| Original Closing Date for Applications: | Oct 01, 2024 |
| Current Closing Date for Applications: | Oct 01, 2024 |
| Archive Date: | Nov 06, 2024 |
| Estimated Total Program Funding: | |
| Award Ceiling: | $300,000 |
| Award Floor: | $ |
Eligibility
| Eligible Applicants: | Small businesses State governments Public housing authorities/Indian housing authorities Others (see text field entitled “Additional Information on Eligibility” for clarification) Independent school districts For profit organizations other than small businesses Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Private institutions of higher education City or township governments Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education County governments Native American tribal organizations (other than Federally recognized tribal governments) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Notice of Funding Opportunity (NOFO) solicits grant applications proposing exploratory research projects focused on further development and validation of emerging technologies offering novel capabilities for targeting, probing, or assessing molecular and cellular features of cancer biology for basic or clinical cancer research. This NOFO solicits R33 applications where major feasibility gaps for the technology or methodology have been overcome, as demonstrated with supportive preliminary data, but still requires further development and rigorous validation to encourage adoption by the research community. Well-suited applications must offer the potential to accelerate and/or enhance research in the areas of cancer biology, early detection and screening, clinical diagnosis, treatment, control, epidemiology, and/or address issues associated with cancer health disparities. Technologies proposed for development may be intended to have widespread applicability but must be focused on improving molecular and/or cellular characterizations of cancer. Projects proposing application of existing technologies where the novelty resides in the biological or clinical target/question being pursued are not appropriate for this solicitation and will not be reviewed. This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-24-009.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact: NIH Grants Information
grantsinfo@nih.gov |